logo-loader
viewScancell Holdings PLC

Scancell Holdings PLC teams up with Sweden's leading research organisation

Discussions with the rheumatology unit at Karolinska Institutet will explore the role of citrullinated proteins in the treatment of cancer.

x-rays.jpg
The scientists are looking to share information.

Drug developer Scancell Holdings PLC (LON:SCLP) is teaming up with Sweden’s leading research organisation -  a collaboration that may aid the development of one of its two breakthrough technologies.

Discussions with the rheumatology unit at Karolinska Institutet will explore the role of citrullinated proteins in the treatment of cancer.

These particular proteins are more commonly associated with arthritis, though Scancell’s work suggests they are key to tumour growth.

This avenue of research led the company to develop the Moditope platform technology that overcomes the immune suppression induced by tumours themselves.

The work of professors Lars Klareskog and Vivianne Malmström, of the Karolinska Institutet, has focused on rheumatoid arthritis.

“We believe that this strategic collaboration with Karolinska will enhance our joint understanding of the role that citrullination plays in both cancer and rheumatoid arthritis, and will help us develop the Moditope platform to its full potential," said professor Lindy Durrant, joint chief executive of Scancell who is also Professor of Cancer Immunotherapy at Nottingham University.

Quick facts: Scancell Holdings PLC

Price: 6.4 GBX

LSE:SCLP
Market: LSE
Market Cap: £29.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Scancell Holdings PLC named herein, including the promotion by the Company of Scancell Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Richard Goodfellow Presents on Behalf of Scancell at the Biotech Capital...

Richard Goodfellow Presents on Behalf of Scancell at the Biotech Capital Conference 

on 03/08/2016

2 min read